HER 2 Win

HER 2 Win

7 October 2022 webinar

President: Paolo Marchetti

In the last year the HER2 positive disease has undergone to a real revolution. The landscape has been radically changed with the advent of new therapeutic strategies. The knowledge of the biological mechanisms underlying this tumour type plays a crucial role to identify the best therapeutic path for cancer patients.
In this course, opinion leaders provide a moment of scientific development and constructive dialogue able to ensure an event of high impact.


Comments are closed